EXPERIENCE IN THE TREATMENT OF ERECTILE DYSFUNCTION USING THE INTRACAVERNOSAL SELF-INJECTION OF PAPAVERINE - RESULTS OF A PROSPECTIVE-STUDY AFTER A MEDIAN FOLLOW-UP OF 42 MONTHS INVOLVING 135 PATIENTS AND 10766 INJECTIONS - Research portal of Justus Liebig University Giessen:

Journal article

EXPERIENCE IN THE TREATMENT OF ERECTILE DYSFUNCTION USING THE INTRACAVERNOSAL SELF-INJECTION OF PAPAVERINE - RESULTS OF A PROSPECTIVE-STUDY AFTER A MEDIAN FOLLOW-UP OF 42 MONTHS INVOLVING 135 PATIENTS AND 10766 INJECTIONS

Authors list: WEIDNER, W; SCHROEDERPRINTZEN, I; FISCHER, C; RUDNICK, J; ALTINKILIC, B; BRAHLER, E

Publication year: 1992

Pages: 179-182

Journal: World Journal of Urology

Volume number: 10

Issue number: 3

ISSN: 0724-4983

DOI Link: https://doi.org/10.1007/BF00213675

Publisher: Springer

Abstract:
The study population comprised 135 patients with impotence of differing etiologic origin who were initially instructed in the self-injection of papaverine. At the end of the study, 91 men (67.4%) continued to participate after a median follow-up period of 42 months (range, 16-60 months) and a median number of 101 (range, 37-295) injections. Of the 44 men (32.6%) who discontinued therapy, only 8 had reached a point where they could dispense with self-injection. The most important reasons for discontinuation were complications, including abnormalities in liver enzymes in 4 men (3%) and recurrent urethral misinjection in 3 men (2.2%). Prolonged erections, which were recorded in 15 men (11.1%), represented <0.1% of the total of 10766 reported injections; 9 of these men continued self-injection without experiencing further episodes of priapism (4 with a decreased amount of papaverine and 5 with prostaglandin E1). Penile nodes were observed in 15 cases (11.1%), and fibrosis of cavernous tissue was evident in 4 men (3%). The development of these complications did not depend on the number, time, or dose of injections.

Citation Styles

Harvard Citation style: WEIDNER, W., SCHROEDERPRINTZEN, I., FISCHER, C., RUDNICK, J., ALTINKILIC, B. and BRAHLER, E. (1992) EXPERIENCE IN THE TREATMENT OF ERECTILE DYSFUNCTION USING THE INTRACAVERNOSAL SELF-INJECTION OF PAPAVERINE - RESULTS OF A PROSPECTIVE-STUDY AFTER A MEDIAN FOLLOW-UP OF 42 MONTHS INVOLVING 135 PATIENTS AND 10766 INJECTIONS, World Journal of Urology, 10(3), pp. 179-182. https://doi.org/10.1007/BF00213675

APA Citation style: WEIDNER, W., SCHROEDERPRINTZEN, I., FISCHER, C., RUDNICK, J., ALTINKILIC, B., & BRAHLER, E. (1992). EXPERIENCE IN THE TREATMENT OF ERECTILE DYSFUNCTION USING THE INTRACAVERNOSAL SELF-INJECTION OF PAPAVERINE - RESULTS OF A PROSPECTIVE-STUDY AFTER A MEDIAN FOLLOW-UP OF 42 MONTHS INVOLVING 135 PATIENTS AND 10766 INJECTIONS. World Journal of Urology. 10(3), 179-182. https://doi.org/10.1007/BF00213675

Keywords

VASOACTIVE DRUGS

SDG Areas